Literature DB >> 23222300

Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13.

Miranda A Hallett1, Katherine T Venmar, Barbara Fingleton.   

Abstract

The Th2 cytokines interleukin (IL)-4 and -13 are acknowledged regulators of lymphocyte proliferation and activation. They have also been well studied in the regulation of various myeloid-derived populations in tumor biology. It has become clear, however, that both cytokines can have direct effects on epithelial tumor cells expressing appropriate receptors. Changes in tumor proliferation, survival, and metastatic capability have all been ascribed to IL-4 and/or IL-13 action. Here, we evaluate the evidence to support direct tumor-promoting roles of these cytokines. We also identify the questions that should be addressed before proceeding with therapeutic approaches based on neutralization of IL-4 or IL-13 pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23222300      PMCID: PMC3531868          DOI: 10.1158/0008-5472.CAN-12-3544

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Epithelial interleukin-4 receptor expression promotes colon tumor growth.

Authors:  Felicitas L Koller; Daniel G Hwang; E A Dozier; Barbara Fingleton
Journal:  Carcinogenesis       Date:  2010-02-22       Impact factor: 4.944

2.  Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

Authors:  Rachel F Gabitass; Nicola E Annels; Deborah D Stocken; Hardev A Pandha; Gary W Middleton
Journal:  Cancer Immunol Immunother       Date:  2011-06-05       Impact factor: 6.968

3.  Cytokine variations in patients with hormone treated prostate cancer.

Authors:  G J Wise; V K Marella; G Talluri; D Shirazian
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

4.  High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis.

Authors:  Rodrigo Barderas; Rubén A Bartolomé; María Jesús Fernandez-Aceñero; Sofia Torres; J Ignacio Casal
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

5.  IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin up-regulation.

Authors:  Hernan Roca; Matthew J Craig; Chi Ying; Zachary S Varsos; Paul Czarnieski; Ajjai S Alva; James Hernandez; David Fuller; Stephanie Daignault; Patrick N Healy; Kenneth J Pienta
Journal:  J Cell Biochem       Date:  2012-05       Impact factor: 4.429

6.  Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4.

Authors:  M Todaro; Y Lombardo; M G Francipane; M Perez Alea; P Cammareri; F Iovino; A B Di Stefano; C Di Bernardo; A Agrusa; G Condorelli; H Walczak; G Stassi
Journal:  Cell Death Differ       Date:  2008-01-18       Impact factor: 15.828

Review 7.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

8.  Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

Authors:  Matilde Todaro; Mileidys Perez Alea; Anna B Di Stefano; Patrizia Cammareri; Louis Vermeulen; Flora Iovino; Claudio Tripodo; Antonio Russo; Gaspare Gulotta; Jan Paul Medema; Giorgio Stassi
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

9.  Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis.

Authors:  Zhiguang Li; Jing Jiang; Zibing Wang; Jinhua Zhang; Mingjie Xiao; Chunhui Wang; Yu Lu; Zhihai Qin
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

10.  A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models.

Authors:  Hideyuki Nakashima; Masaki Terabe; Jay A Berzofsky; Syed R Husain; Raj K Puri
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.426

View more
  48 in total

1.  Higher circulating levels of chemokine CCL22 in patients with breast cancer: evaluation of the influences of tumor stage and chemokine gene polymorphism.

Authors:  A Jafarzadeh; H Fooladseresht; K Minaee; M R Bazrafshani; A Khosravimashizi; M Nemati; M Mohammadizadeh; M M Mohammadi; A Ghaderi
Journal:  Tumour Biol       Date:  2014-10-22

2.  Commentary: IL-4 and IL-13 receptors and signaling.

Authors:  Sarah M McCormick; Nicola M Heller
Journal:  Cytokine       Date:  2015-07-14       Impact factor: 3.861

3.  Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma.

Authors:  Yuan Chang; Le Xu; Huimin An; Qiang Fu; Lian Chen; Zongming Lin; Jiejie Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  Lessons from immunology: IL4R directly promotes mammary tumor metastasis.

Authors:  Katherine T Venmar; Barbara Fingleton
Journal:  Oncoimmunology       Date:  2014-12-13       Impact factor: 8.110

5.  IL-13 induces the expression of 11βHSD2 in IL-13Rα2 dependent manner and promotes the malignancy of colorectal cancer.

Authors:  Li Jiang; Qi Cheng; Binhao Zhang; Mingzhi Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

6.  The receptor NLRP3 is a transcriptional regulator of TH2 differentiation.

Authors:  Mélanie Bruchard; Cédric Rebé; Valentin Derangère; Dieudonnée Togbé; Bernhard Ryffel; Romain Boidot; Etienne Humblin; Arlette Hamman; Fanny Chalmin; Hélène Berger; Angélique Chevriaux; Emeric Limagne; Lionel Apetoh; Frédérique Végran; François Ghiringhelli
Journal:  Nat Immunol       Date:  2015-06-22       Impact factor: 25.606

Review 7.  Targeting IL4/IL4R for the treatment of epithelial cancer metastasis.

Authors:  Katherine Venmar Bankaitis; Barbara Fingleton
Journal:  Clin Exp Metastasis       Date:  2015-09-18       Impact factor: 5.150

8.  IL-4 and IL-17A Cooperatively Promote Hydrogen Peroxide Production, Oxidative DNA Damage, and Upregulation of Dual Oxidase 2 in Human Colon and Pancreatic Cancer Cells.

Authors:  Yongzhong Wu; Mariam M Konaté; Jiamo Lu; Hala Makhlouf; Rodrigo Chuaqui; Smitha Antony; Jennifer L Meitzler; Michael J Difilippantonio; Han Liu; Agnes Juhasz; Guojian Jiang; Iris Dahan; Krishnendu Roy; James H Doroshow
Journal:  J Immunol       Date:  2019-09-23       Impact factor: 5.422

9.  IL4 receptor ILR4α regulates metastatic colonization by mammary tumors through multiple signaling pathways.

Authors:  Katherine T Venmar; Kathy J Carter; Daniel G Hwang; E Ashley Dozier; Barbara Fingleton
Journal:  Cancer Res       Date:  2014-06-19       Impact factor: 12.701

Review 10.  Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma.

Authors:  Wanli Yu; Sai Liang; Chunzhi Zhang
Journal:  Neuromolecular Med       Date:  2018-09-04       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.